Q1 Earnings Roundup: Akamai Beats Estimates, Axon Sees Slight Dip, Cutera Takes a Hit, and Wynn Resorts Holds Steady
- May 09th, 2023
- 615 views
In the latest round of Q1 earnings reports, Akamai Technologies, Inc. (Nasdaq: AKAM) beat consensus estimates with an adjusted EPS of $1.40, compared to the expected $1.32. This news was well-received by investors, as AKAM's stock price increased by $3.62 per share (+4.59%) in after-hours trading, currently trading at $82.50.
On the other hand, Axon Enterprise, Inc. (Nasdaq: AXON) reported a non-GAAP EPS of $0.88 for Q1, which surpassed the consensus estimate of $0.53. However, AXON's stock price saw a slight decrease of $1.88 per share (-0.83%) in after-hours trading and is currently trading at $225.00.
Cutera, Inc. (Nasdaq: CUTR) reported a Q1 loss of $1.26 per share, which was significantly worse than the consensus loss of $0.39 per share. This news led to a significant drop in CUTR's stock price, decreasing by $2.58 per share (-12.77%) in after-hours trading, currently trading at $17.62.
Wynn Resorts, Limited (Nasdaq: WYNN) also reported a Q1 loss of $0.02 per share, slightly worse than the consensus loss of $0.01 per share. However, WYNN's stock price saw a small increase of $0.79 per share (+0.71%) in after-hours trading and is currently trading at $112.49.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
DOT, DoW, DHS Join Forces to Protect Southern Border Airspace
October 16th, 2026FTC Sues Ticket Broker Over Unlawful Tactics Used to Buy Millions of Tickets to Popular Live Events
October 15th, 2026October 15th, 2026FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer
October 14th, 2026U.S. Treasury Announces Record Enforcement Actions Against Bank of America
October 14th, 2026




Member Login